Bronchiectasis: An update

Research output: Contribution to journalArticle

Abstract

Bronchiectasis produced severe morbidity in patients in the preantibiotic era. Virulent bacterial pulmonary infections, including tuberculosis, caused irreversible lung damage. Secretions pooled in cystic and ectatic airways resulted in repeated episodes of acute bronchitis and pneumonia. Hemoptysis, respiratory impairment, and cor pulmonale were sequelae of the original infection. Effective antibiotics for treatment of respiratory infections have reduced the prevalence of bronchiectasis, but have not eliminated it. New diagnostic techniques and new means to determine the etiology of bronchiectasis may help clinicians to move closer toward elimination of this disease. Suppressive antimicrobial therapy probably is an effective management therapy.

Original languageEnglish (US)
Pages (from-to)46-52
Number of pages7
JournalInfections in Medicine
Volume9
Issue number10
StatePublished - 1992

Fingerprint

Bronchiectasis
Disease Eradication
Pulmonary Heart Disease
Lung
Hemoptysis
Bronchitis
Bacterial Infections
Respiratory Tract Infections
Pneumonia
Tuberculosis
Therapeutics
Anti-Bacterial Agents
Morbidity
Infection

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Bronchiectasis : An update. / Barker, Alan.

In: Infections in Medicine, Vol. 9, No. 10, 1992, p. 46-52.

Research output: Contribution to journalArticle

Barker, A 1992, 'Bronchiectasis: An update', Infections in Medicine, vol. 9, no. 10, pp. 46-52.
Barker, Alan. / Bronchiectasis : An update. In: Infections in Medicine. 1992 ; Vol. 9, No. 10. pp. 46-52.
@article{525b1d66dfe34afaadcbcb47220c49a9,
title = "Bronchiectasis: An update",
abstract = "Bronchiectasis produced severe morbidity in patients in the preantibiotic era. Virulent bacterial pulmonary infections, including tuberculosis, caused irreversible lung damage. Secretions pooled in cystic and ectatic airways resulted in repeated episodes of acute bronchitis and pneumonia. Hemoptysis, respiratory impairment, and cor pulmonale were sequelae of the original infection. Effective antibiotics for treatment of respiratory infections have reduced the prevalence of bronchiectasis, but have not eliminated it. New diagnostic techniques and new means to determine the etiology of bronchiectasis may help clinicians to move closer toward elimination of this disease. Suppressive antimicrobial therapy probably is an effective management therapy.",
author = "Alan Barker",
year = "1992",
language = "English (US)",
volume = "9",
pages = "46--52",
journal = "Infections in Medicine",
issn = "0749-6524",
publisher = "CMP Healthcare Media LLC",
number = "10",

}

TY - JOUR

T1 - Bronchiectasis

T2 - An update

AU - Barker, Alan

PY - 1992

Y1 - 1992

N2 - Bronchiectasis produced severe morbidity in patients in the preantibiotic era. Virulent bacterial pulmonary infections, including tuberculosis, caused irreversible lung damage. Secretions pooled in cystic and ectatic airways resulted in repeated episodes of acute bronchitis and pneumonia. Hemoptysis, respiratory impairment, and cor pulmonale were sequelae of the original infection. Effective antibiotics for treatment of respiratory infections have reduced the prevalence of bronchiectasis, but have not eliminated it. New diagnostic techniques and new means to determine the etiology of bronchiectasis may help clinicians to move closer toward elimination of this disease. Suppressive antimicrobial therapy probably is an effective management therapy.

AB - Bronchiectasis produced severe morbidity in patients in the preantibiotic era. Virulent bacterial pulmonary infections, including tuberculosis, caused irreversible lung damage. Secretions pooled in cystic and ectatic airways resulted in repeated episodes of acute bronchitis and pneumonia. Hemoptysis, respiratory impairment, and cor pulmonale were sequelae of the original infection. Effective antibiotics for treatment of respiratory infections have reduced the prevalence of bronchiectasis, but have not eliminated it. New diagnostic techniques and new means to determine the etiology of bronchiectasis may help clinicians to move closer toward elimination of this disease. Suppressive antimicrobial therapy probably is an effective management therapy.

UR - http://www.scopus.com/inward/record.url?scp=0026970257&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026970257&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0026970257

VL - 9

SP - 46

EP - 52

JO - Infections in Medicine

JF - Infections in Medicine

SN - 0749-6524

IS - 10

ER -